HBM Healthcare Investments AG, founded in 2001 and based in Basel, Switzerland, is an investment company focused on the healthcare sector. It aims to deliver long-term capital appreciation by investing in a diversified portfolio of companies in the biotech and pharmaceutical industries.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| HBMASW 1.13% 2027-07-12 CHFHBM Healthcare Investments AG | Switzerland | 2027-07-12 | 1.125 | 1.06 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, HBM Healthcare Investments AG has successfully issued bonds to fund its investment strategies, with notable issuances occurring in 2015 and 2020, aimed at raising capital for expanding its portfolio. The company's bonds, known for their solid yields, currently yield around 4.5%, which is competitive compared to industry averages. In 2021, the company introduced a unique convertible bond feature, allowing bondholders to convert their holdings into shares at a premium, reflecting its commitment to innovative financing solutions.